Intra-Cellular Therapies
ITCI
#1264
Rank
โ‚น1.201 T
Marketcap
โ‚น11,276
Share price
0.00%
Change (1 day)
82.94%
Change (1 year)

EPS for Intra-Cellular Therapies (ITCI)

EPS in 2023 (TTM): -โ‚น132.73

According to Intra-Cellular Therapies's latest financial reports the company's current EPS (TTM) is -โ‚น137.67. In 2022 the company made an earnings per share (EPS) of -โ‚น232.58 an increase over its 2021 EPS that were of -โ‚น299.28.

EPS history for Intra-Cellular Therapies from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น132.73-42.93%
2022-โ‚น232.58-22.29%
2021-โ‚น299.288.02%
2020-โ‚น277.0520.9%
2019-โ‚น229.16-5.63%
2018-โ‚น242.8533.96%
2017-โ‚น181.28-21.19%
2016-โ‚น230.02-7.56%
2015-โ‚น248.83174.53%
2014-โ‚น90.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น21.38-84.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น855.09 521.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น182.99 32.92%๐Ÿ‡บ๐Ÿ‡ธ USA